Telavant, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2022-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.telavanttx.com
Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Phase 2
2 (50.0%)Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's Disease
Phase 2
Withdrawn
- Conditions
- Crohn Disease
- Interventions
- Drug: Investigational ProductDrug: Placebo
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Telavant, Inc.
- Registration Number
- NCT05471492
Evaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy Participants
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Telavant, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT04269538
- Locations
- 🇯🇵
P-one Clinic, Hachioji-shi, Tokyo, Japan
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
- First Posted Date
- 2016-07-21
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Telavant, Inc.
- Target Recruit Count
- 50
- Registration Number
- NCT02840721
- Locations
- 🇺🇸
Surgery Center of Aventura, Aventura, Florida, United States
🇺🇸Venture Ambulatory Surgical Center, North Miami Beach, Florida, United States
🇺🇸FQL Research, LLC, Pembroke Pines, Florida, United States
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects.
- First Posted Date
- 2013-11-20
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Telavant, Inc.
- Target Recruit Count
- 92
- Registration Number
- NCT01989143
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
News
No news found